# Radiopharmaceutical Treatment of Advanced Kidney Cancer

> **NCT06783348** · PHASE2 · NOT_YET_RECRUITING · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 48 (estimated)

## Conditions studied

- Metastatic Clear Cell Renal Cell Carcinoma

## Interventions

- **DRUG:** 177Lu-PSMA-617

## Key facts

- **NCT ID:** NCT06783348
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-30
- **Primary completion:** 2028-01-30
- **Final completion:** 2029-01-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06783348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06783348, "Radiopharmaceutical Treatment of Advanced Kidney Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06783348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*